Benjamin Amidon

891 total citations
9 papers, 284 citations indexed

About

Benjamin Amidon is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Benjamin Amidon has authored 9 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Oncology. Recurrent topics in Benjamin Amidon's work include Ubiquitin and proteasome pathways (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Cancer-related Molecular Pathways (2 papers). Benjamin Amidon is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Hippo pathway signaling and YAP/TAZ (2 papers) and Cancer-related Molecular Pathways (2 papers). Benjamin Amidon collaborates with scholars based in United States and Japan. Benjamin Amidon's co-authors include Moseley Waite, Peter G. Smith, Petter O. Veiby, Teresa A. Soucy, Michael A. Milhollen, Usha Narayanan, Amy Brown, Lynn King, Jeffrey D. Schmitt and Tom Thurén and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Cancer Research.

In The Last Decade

Benjamin Amidon

8 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benjamin Amidon United States	7	227	86	81	37	31	9	284
Daniel J. Termine United States	6	118 0.5×	44 0.5×	97 1.2×	38 1.0×	32 1.0×	6	236
Lauren A. Howell United States	9	242 1.1×	38 0.4×	98 1.2×	28 0.8×	77 2.5×	11	313
Lindsay Ryland United States	3	198 0.9×	26 0.3×	49 0.6×	35 0.9×	20 0.6×	5	273
Quyen Thu Bui South Korea	7	190 0.8×	93 1.1×	37 0.5×	17 0.5×	28 0.9×	11	279
Nicholas Johnston United States	6	215 0.9×	92 1.1×	23 0.3×	22 0.6×	14 0.5×	7	316
Adam Gastonguay United States	11	209 0.9×	47 0.5×	52 0.6×	19 0.5×	25 0.8×	11	346
Yue Xiong United States	6	349 1.5×	254 3.0×	29 0.4×	29 0.8×	36 1.2×	24	438
Tianmu Wen United States	8	166 0.7×	54 0.6×	91 1.1×	15 0.4×	25 0.8×	13	260
Lisa Ellmann Germany	9	212 0.9×	29 0.3×	23 0.3×	34 0.9×	17 0.5×	9	266
Nick Hoogenraad Australia	8	268 1.2×	29 0.3×	72 0.9×	90 2.4×	34 1.1×	12	361

Countries citing papers authored by Benjamin Amidon

Since Specialization

Citations

This map shows the geographic impact of Benjamin Amidon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Amidon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Amidon more than expected).

Fields of papers citing papers by Benjamin Amidon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Amidon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Amidon. The network helps show where Benjamin Amidon may publish in the future.

Co-authorship network of co-authors of Benjamin Amidon

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Amidon. A scholar is included among the top collaborators of Benjamin Amidon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Amidon. Benjamin Amidon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Amidon, Benjamin, Wilmin Bartolini, Karen McGovern, et al.. (2022). Abstract 2156: IK-930 is a novel TEAD inhibitor for the treatment of cancers harboring mutations in the Hippo signal transduction pathway. Cancer Research. 82(12_Supplement). 2156–2156. 14 indexed citations

Amidon, Benjamin, Jill Cavanaugh, Katie O’Callaghan, et al.. (2021). Abstract P216: IK-930 mediated TEAD inhibition decreases and delays tumor growth and enhances targeted apoptosis in lung and colon cancer xenografts when combined with MEK or EGFR inhibitors. Molecular Cancer Therapeutics. 20(12_Supplement). P216–P216. 7 indexed citations

Amidon, Benjamin, Dongyun Wu, John Bradley, et al.. (2017). Abstract 1493: LonP1 is required for tumor maintenance and growth. Cancer Research. 77(13_Supplement). 1493–1493. 1 indexed citations

Shinde, Vaishali, Bradley Stringer, Mark G. Qian, et al.. (2012). MLN0905, a Small-Molecule PLK1 Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma. Molecular Cancer Therapeutics. 11(9). 2045–2053. 16 indexed citations

Gavin, James M., Hua Liao, Xiaofeng Yang, et al.. (2012). Mechanistic Studies on Activation of Ubiquitin and Di-ubiquitin-like Protein, FAT10, by Ubiquitin-like Modifier Activating Enzyme 6, Uba6. Journal of Biological Chemistry. 287(19). 15512–15522. 31 indexed citations

Milhollen, Michael A., Usha Narayanan, Teresa A. Soucy, et al.. (2011). Inhibition of NEDD8-Activating Enzyme Induces Rereplication and Apoptosis in Human Tumor Cells Consistent with Deregulating CDT1 Turnover. Cancer Research. 71(8). 3042–3051. 130 indexed citations

Blackman, Ronald K. & Benjamin Amidon. (2004). Microarray Approach for Cloned Library Quality Assessment and the Comprehensive Identification of Positives from Library Screens. BioTechniques. 37(4). 536–540.

Amidon, Benjamin, Amy Brown, & Moseley Waite. (1996). Transacylase and Phospholipases in the Synthesis of Bis(monoacylglycero)phosphate. Biochemistry. 35(44). 13995–14002. 52 indexed citations

Amidon, Benjamin, Jeffrey D. Schmitt, Tom Thurén, Lynn King, & Moseley Waite. (1995). Biosynthetic conversion of phosphatidylglycerol to sn-1:sn-1' bis(monoacylglycerol) phosphate in a macrophage-like cell Line. Biochemistry. 34(16). 5554–5560. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact